Risk of overtreatment with current peak flow criteria in self- management plans

European Respiratory Journal

Volumn 12, Issue 4, 1998, Pages 848-852

  Douma, W R ^a   Kerstjens, H A M ^a   Rooyackers, J M ^b   Koeter G H ^a   Postma, D S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Asthma; Peak expiratory flow; Self management plans

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; SELF CARE;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEALTH SERVICES MISUSE; HUMANS; IPRATROPIUM; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SELF ADMINISTRATION; TERBUTALINE; TREATMENT OUTCOME;

EID: 0031783945     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12040848     Document Type: Article

References (20)

1. British Thoracic Society. Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. Guidelines for management of asthma in adults: I. chronic persistent asthma. Br Med J 1990; 301: 651-653.
2. British Thoracic Society. Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. Guidelines for management of asthma in adults: II. acute severe asthma. Br Med J 1990; 301: 797-800.
3. National Heart, Lung and Blood Institute, National Asthma Education Program, Expert Panel Report. Guidelines for the diagnosis and management of asthma. J Allergy din Immunol 1991; 88: (Suppl.), 425-534.
4. Brewis RAL. Patient education, self-management plans and peak flow measurement. Respir Med 1991; 85: 457-462.
5. International Asthma Management Project. International consensus report on the diagnosis and treatment of asthma. Bethesda, MD, NHLBI, NIH, 1992; publication no. 92-3091: pp. 1-72.
6. British Thoracic Society. Guidelines on the management of asthma. Thorax 1993; 48: Suppl., S1-S24.
7. Kotses H, Bernstein IL, Bernstein DI, et al. A self-management program for adult asthma. Part 1; Development and evaluation. J Allergy Clin Immunol 1995; 95: 529-540.
8. Grampian Asthma Study of Integrated Care (GRASSIC). Effectiveness of routine self monitering of peak flow in patients with asthma. Br Med J 1994; 308: 564-567.
9. Taitel MS, Kotses H, Bernstein L, Bernstein DI, Creer TL. A self-management program for adult asthma. Part 2; Cost-benefit analysis. J Allergy Clin Immunol 1995; 95: 672-676.
10. Lahdensuo A, Haahtela T, Herrala J, et al. Randomized comparison of guided self-management and traditional treatment of asthma over one year. Br Med J 1996; 312: 748-752.
11. Ignacio-Garcia JM, Gonzalez-Santos P. Asthma self-management education program by home monitoring of peak expiratory flow. Am J Respir Crit Care Med 1995; 151: 353-359.
12. Meijer RJ, Kerstjens HAM, Postma DS. Guidelines and self-management plans in asthma. Eur Respir J 1997; 10: 1163-1172.
13. Kerstjens HAM, Brand PLP, Hughes MD, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992; 327: 1413-1419.
14. Brand PLP, Quanjer PH, Postma DS, et al. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax 1992; 47: 429-436.
15. Quanjer PH. Standardized lung function testing. Bull Eur Physiopathol Respir 1983; 19: Suppl. 5, 1-95.
16. Brand PLP, Kerstjens HAM, Postma DS, et al. Long-term multicentre trial in chronic nonspecific lung disease: methodology and baseline assessment in adult patients. Eur Respir J 1992; 5: 21-31.
17. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7: 235-243.
18. Brand PLP, Kersjens HAM, Janson HM, Kauffman HF, de Monchly JGR, Dutch CNCLD Study Group. Interpretation of skin tests to house dust mite and relationship to other allergy parameters in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993; 91: 560-570.
19. Quanjer PH, Tammeling GL, Cotes JE, Pederson OF, Peslin R, Yernault YC. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6: Suppl. 16, 5-40.
20. Gibson PG, Wlodarczyk J, Henzley MJ, Murree-Allen K, Olson LG, Saltos N. Using quality control analysis of peak expiratory flow recordings to guide therapy for asthma. Ann Intern Med 1995; 123: 488-492.